PRL-3 Mediates the Protein Maturation of ULBP2 by Regulating the Tyrosine Phosphorylation of HSP60

  • Leung W
  • Vong Q
  • Lin W
  • et al.
18Citations
Citations of this article
30Readers
Mendeley users who have this article in their library.

Abstract

Many malignant cells release the NKG2D ligand ULBP2 from their cell surface to evade immunosurveillance by NK cells and CD8 T cells. Although the shedding mechanism remains unclear, various inhibitors of matrix metalloproteinases have been shown to efficiently block the release of soluble ULBP2. The clinical use of these inhibitors, however, is limited because of adverse side effects. Using high-throughput screening technique, we identified a specific inhibitor of phosphatase of regenerating liver 3 (PRL-3) that could reduce the level of soluble ULBP2 in the culture supernatant of various cancer cell lines. Inhibition or gene knockdown of PRL-3 did not reduce ULBP2 shedding, but rather suppressed posttranslational maturation of ULBP2, resulting in intracellular retention of immature ULBP2. We then found that ULBP2 was constitutively associated with heat shock protein HSP60. Complete maturation of ULBP2 required tyrosine phosphorylation of HSP60 which was mediated by PRL-3.

References Powered by Scopus

Matrix metalloproteinase inhibitors and cancer: Trials and tribulations

2496Citations
N/AReaders
Get full text

Global Survey of Phosphotyrosine Signaling Identifies Oncogenic Kinases in Lung Cancer

2065Citations
N/AReaders
Get full text

The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor

1109Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Hsp60 Post-translational Modifications: Functional and Pathological Consequences

103Citations
N/AReaders
Get full text

Roles of astrocytic connexin-43, hemichannels, and gap junctions in oxygen-glucose deprivation/reperfusion injury induced neuroinflammation and the possible regulatory mechanisms of salvianolic acid B and carbenoxolone

88Citations
N/AReaders
Get full text

PRL3-zumab, a first-in-class humanized antibody for cancer therapy

45Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Leung, W.-H., Vong, Q. P., Lin, W., Bouck, D., Wendt, S., Sullivan, E., … Leung, W. (2015). PRL-3 Mediates the Protein Maturation of ULBP2 by Regulating the Tyrosine Phosphorylation of HSP60. The Journal of Immunology, 194(6), 2930–2941. https://doi.org/10.4049/jimmunol.1400817

Readers over time

‘15‘16‘17‘18‘19‘20‘21‘22‘2302468

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 11

65%

Researcher 4

24%

Professor / Associate Prof. 2

12%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 6

40%

Agricultural and Biological Sciences 5

33%

Medicine and Dentistry 3

20%

Chemistry 1

7%

Save time finding and organizing research with Mendeley

Sign up for free
0